Abstract
Although some myokines exert their actions on other organs in a hormone–like fashion, many of them operate locally on skeletal muscle themselves. Myokines may thereby provide a feedback loop for the muscle to regulate its own growth and regeneration allowing for adaptation to exercise training. The myokine concept provides a conceptual basis and a whole new paradigm for understanding how muscles communicate with other organs within the muscle itself. New biotechnological patents are published based on the identification of new myokines, and these myokines and their receptors will potentially serve as pharmacological targets for treating muscle diseases, metabolic disorders and other diseases associated with muscle disuse.
Keywords: Skeletal muscle, exercise, metabolism, metabolic diseases, activity, inactivity, muscle, muscle cells, myoblasts, myocytes, myogenesis, cytokines, myokines, interleukins, IL-6, irisin, muscle wasting, muscular dystrophies, sarcopenia, patents
Recent Patents on Biotechnology
Title:Myokines in Myogenesis and Health
Volume: 6 Issue: 3
Author(s): Tora Henriksen, Charlotte Green and Bente Klarlund Pedersen
Affiliation:
Keywords: Skeletal muscle, exercise, metabolism, metabolic diseases, activity, inactivity, muscle, muscle cells, myoblasts, myocytes, myogenesis, cytokines, myokines, interleukins, IL-6, irisin, muscle wasting, muscular dystrophies, sarcopenia, patents
Abstract: Although some myokines exert their actions on other organs in a hormone–like fashion, many of them operate locally on skeletal muscle themselves. Myokines may thereby provide a feedback loop for the muscle to regulate its own growth and regeneration allowing for adaptation to exercise training. The myokine concept provides a conceptual basis and a whole new paradigm for understanding how muscles communicate with other organs within the muscle itself. New biotechnological patents are published based on the identification of new myokines, and these myokines and their receptors will potentially serve as pharmacological targets for treating muscle diseases, metabolic disorders and other diseases associated with muscle disuse.
Export Options
About this article
Cite this article as:
Henriksen Tora, Green Charlotte and Klarlund Pedersen Bente, Myokines in Myogenesis and Health, Recent Patents on Biotechnology 2012; 6 (3) . https://dx.doi.org/10.2174/1872208311206030167
DOI https://dx.doi.org/10.2174/1872208311206030167 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System
Current Pharmaceutical Design Headache: One of the Most Common and Troublesome Adverse Reactions to Drugs
Current Drug Safety The Circulating Endothelial Cell in Cancer: Towards Marker and Target Identification
Current Pharmaceutical Design Role of the Non-Receptor Tyrosine Kinase Fes in Cancer
Current Medicinal Chemistry Drug Targets in Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection
Infectious Disorders - Drug Targets Aptamer-Mediated Cancer Gene Therapy
Current Gene Therapy Virus, Oncolytic Virus and Human Prostate Cancer
Current Cancer Drug Targets New Purine Nucleoside Analogs for Acute Lymphoblastic Leukemia
Clinical Cancer Drugs Bisacylimidoselenocarbamates Cause G2/M Arrest Associated with the Modulation of CDK1 and Chk2 in Human Breast Cancer MCF-7 Cells
Current Medicinal Chemistry Direct Modification of Bioactive Phenothiazines by Exposure to Laser Radiation
Recent Patents on Anti-Infective Drug Discovery De Novo Design of New Inhibitor of Mutated Tyrosine-Kinase for the Myeloid Leukemia Treatment
Current Pharmaceutical Design Recent Innovations in Antibody-Mediated, Targeted Particulate Nanotechnology and Implications for Advanced Visualisation and Drug Delivery
Current Nanoscience Resistance in Cancer: A Target for Drug Discovery
Current Medicinal Chemistry - Anti-Cancer Agents CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies
Current Cancer Drug Targets Improving Safety of Gene Therapy
Current Drug Safety Genetically Modified Cellular Vaccines for Therapy of Human Papilloma Virus Type 16 (HPV 16)-Associated Tumours
Current Cancer Drug Targets Alzheimer’s Disease and Autistic Spectrum Disorder: Is there any Association?
CNS & Neurological Disorders - Drug Targets Exploring and Exploiting Biologically Relevant Chemical Space
Current Drug Targets World Health Organization Classification of Myelodysplastic Syndromes
Current Pharmaceutical Design The Involvement of Heat Shock Proteins and Related Molecules in the Resistance to Therapies in Breast and Gynecologic Cancer
Current Cancer Therapy Reviews